EP 4110825 A1 20230104 - NOVEL HUMAN THERAPEUTIC MONOCLONAL ANTIBODIES AND USES THEREOF
Title (en)
NOVEL HUMAN THERAPEUTIC MONOCLONAL ANTIBODIES AND USES THEREOF
Title (de)
NEUE MENSCHLICHE THERAPEUTISCHE MONOKLONALE ANTIKÖRPER UND DEREN VERWENDUNGEN
Title (fr)
NOUVEAUX ANTICORPS MONOCLONAUX THERAPEUTIQUES HUMAINS ET LEURS UTILISATIONS
Publication
Application
Priority
- FR 1911722 A 20191018
- EP 2020079208 W 20201016
Abstract (en)
[origin: WO2021074376A1] The invention relates to novel human therapeutic monoclonal antibodies and to the uses thereof.
IPC 8 full level
C07K 16/40 (2006.01); A61K 49/00 (2006.01); A61P 9/00 (2006.01)
CPC (source: EP US)
A61P 9/00 (2017.12 - EP); A61P 9/14 (2017.12 - US); C07K 16/40 (2013.01 - EP US); G01N 33/564 (2013.01 - EP); G01N 33/573 (2013.01 - EP); A61K 39/00 (2013.01 - US); C07K 2317/21 (2013.01 - EP); C07K 2317/34 (2013.01 - EP); C07K 2317/52 (2013.01 - EP); C07K 2317/526 (2013.01 - EP); C07K 2317/55 (2013.01 - EP); C07K 2317/76 (2013.01 - EP); C07K 2317/92 (2013.01 - EP); G01N 2333/96441 (2013.01 - EP); G01N 2800/12 (2013.01 - EP); G01N 2800/328 (2013.01 - EP)
Citation (search report)
See references of WO 2021074376A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
FR 3102175 A1 20210423; FR 3102175 B1 20211001; EP 4110825 A1 20230104; US 2023203197 A1 20230629; WO 2021074376 A1 20210422
DOCDB simple family (application)
FR 1911722 A 20191018; EP 2020079208 W 20201016; EP 20792417 A 20201016; US 202017926817 A 20201016